EUVIMEDEUVIMED entdecken
Crossref

Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers

Marcelo Paes Menezes Filho, Luiz Sergio Fonseca de Azevedo, Lais Teodoro da Silva, Juliana Ruiz Fernandes, Telma Oshiro Sumida, Beatriz Trevisan, Fabiana Agena, Elias Davi-Neto, Gil Bernard

Transplantation Proceedings · 2026

DOI: 10.1016/j.transproceed.2026.06.029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Marcelo Paes Menezes Filho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Transplantation Service, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil. Electronic…. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Immunogenicity, Vaccine, COVID-19. Die Arbeit nennt 13 Literaturangaben. Gefördert von: State of Sao Paulo Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In kidney transplant recipients (KTRs), the immunogenic response to vaccines is considered to be low in achieving a robust immune response. METHODS: This study evaluated the serological response of KTRs who received previous immunization with the anti-SARS-CoV-2 vaccine ChAdOx1 and 2 booster doses of BNT162b2 vaccine. Patients were on 3 different immunosuppressive regimens: azathioprine (AZA), mycophenolic acid precursors (MPA), or mammalian target of rapamycin inhibitors (mTORi). All were also on tacrolimus and prednisone. Healthy volunteers served as controls. Blood samples were collected before receiving the first booster dose, 4 to 6 weeks after the first booster dose, and 6 months after the second booster dose. RESULTS: Before the vaccine booster, the MPA group had a tendency, but not statistically significant, of a lower reactivity rate than the AZA, mTORi, and control groups. The percentage of reactivity was AZA 54%, MPA 42%, mTORi 55%, and controls 73%, respectively. After the first booster, the serological response had a significant increase, indicating the effectiveness of the heterologous vaccine dose in all groups (P < .05 in percentage of responders in serological titers), which reached the following percentage of seroreactivity: AZA 90%, MPA 80%, mTORi 88%, and controls 100%, respectively. After the second booster dose, seroreactivity was 81%, 91%, and 100%, respectively. CONCLUSIONS: After the vaccine booster, there was no statistically significant difference in IgG titers among the AZA, MPA, and mTORi groups in KTRs that demonstrated that the additional booster regimen with BNT162b2 increased the initial low responsiveness, increasing seroconversion rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsImmunogenicity, VaccineCOVID-19Antibodies, ViralSARS-CoV-2COVID-19 VaccinesHumansMaleFemaleAdultMiddle AgedMycophenolic AcidAzathioprineTacrolimusBNT162 VaccineImmunization, Secondary

Substanzen

Immunosuppressive AgentsMycophenolic AcidAntibodies, ViralAzathioprineTacrolimusBNT162 VaccineCOVID-19 Vaccines

Autor:innen und Institutionen

  • Kidney Transplantation Service, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil. Electronic address: marcelo.filho@fbpn-campos.com.br.
  • Kidney Transplantation Service, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
  • Medical Investigation Laboratory (LIM56). Department of Dermatology. Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.

Förderung

  • State of Sao Paulo Research Foundation

Zitieren

APA

Menezes Filho, M. P., de Azevedo, L. S. F., da Silva, L. T., Fernandes, J. R., Sumida, T. O., Trevisan, B., Agena, F., Davi-Neto, E., & Bernard, G. (2026). Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.06.029

Vancouver

Menezes Filho MP, de Azevedo LSF, da Silva LT, Fernandes JR, Sumida TO, Trevisan B, et al. Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.06.029

BibTeX
@article{MenezesFilho2026,
  author = {Menezes Filho, Marcelo Paes and de Azevedo, Luiz Sergio Fonseca and da Silva, Lais Teodoro and Fernandes, Juliana Ruiz and Sumida, Telma Oshiro and Trevisan, Beatriz and Agena, Fabiana and Davi-Neto, Elias and Bernard, Gil},
  title = {Vaccine Immunogenicity to SARS-CoV-2 in Renal Transplant Patients Under Three Different Immunosuppressive Regimens: Evaluation of Antibody Titers},
  journal = {Transplantation Proceedings},
  year = {2026},
  doi = {10.1016/j.transproceed.2026.06.029}
}
Kostenlos starten →